Apotex Makes 2nd Acquisition in Europe by Purchasing Lareq Pharma of Spain
Lareq, founded in 1984 and dedicated to generics since 1996, is a mid-sized generic pharmaceutical company. With 12 generic registrations, several pending near-term launches and products in development, Lareq is the 13th largest player in the retail pharmacy generics segment, according to the company. It benefits from strong brand recognition amongst pharmacists, and a nation-wide sales force that reaches Spain's retail pharmacies.
Just recently, Apotex announced the acquisition of Topgen of Belgium from the Zambon Group. "The acquisitions in Belgium and Spain, as well as our new affiliate in Turkey, are clear signals of our commitment to growth outside Canada and the US" continues Andrew Kay.
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.